Showing results (1561-1570 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|April 8, 1998
Behavioural toxicity of medicinal drugs. Practical consequences, incidence, management and avoidanceJ G Ramaekers
Drug Safety|December 10, 1997
Therapeutic options for HIV-associated bodyweight loss. A risk-benefit analysisV Stosor, J V Roenn
Drug Safety|December 10, 1997
Heparin-induced thrombocytopenia. Pathogenesis, frequency, avoidance and managementT E Warkentin
Drug Safety|June 25, 1998
Drug-food interactions in hospitalised patients. Methods of preventionI Gauthier, M Malone
Drug Safety|April 7, 2021
Population-Based Observational Study of Adverse Drug Event-Related Mortality in the Super-Aged Society of JapanTomoko Funahashi, Toshihiro Koyama, Hideharu Hagiya, et al.
Drug Safety|June 26, 2015
Pharmacogenetics of Drug-Induced QT Interval Prolongation: An UpdateMaartje N Niemeijer, Marten E van den Berg, Mark Eijgelsheim, et al.
Drug Safety|July 1, 2015
Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control AnalysisPatrick Imfeld, Michael Bodmer, Susan S Jick, et al.
Drug Safety|July 9, 2015
A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug ReactionsYing Li, Patrick B Ryan, Ying Wei, et al.
Drug Safety|May 31, 2015
Electronic Health Data for Postmarket Surveillance: A Vision Not RealizedThomas J Moore, Curt D Furberg
Drug Safety|June 10, 2015
A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety SurveillanceYihua Xu, Xiaofeng Zhou, Brandon T Suehs, et al.
Pageof 311